JP2021527130A5 - - Google Patents
Info
- Publication number
- JP2021527130A5 JP2021527130A5 JP2021518059A JP2021518059A JP2021527130A5 JP 2021527130 A5 JP2021527130 A5 JP 2021527130A5 JP 2021518059 A JP2021518059 A JP 2021518059A JP 2021518059 A JP2021518059 A JP 2021518059A JP 2021527130 A5 JP2021527130 A5 JP 2021527130A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- iodide
- subject
- disease
- injury
- Prior art date
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862682574P | 2018-06-08 | 2018-06-08 | |
| US62/682,574 | 2018-06-08 | ||
| US201862730927P | 2018-09-13 | 2018-09-13 | |
| US201862730945P | 2018-09-13 | 2018-09-13 | |
| US62/730,945 | 2018-09-13 | ||
| US62/730,927 | 2018-09-13 | ||
| PCT/US2019/036154 WO2019237065A1 (en) | 2018-06-08 | 2019-06-07 | Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527130A JP2021527130A (ja) | 2021-10-11 |
| JP2021527130A5 true JP2021527130A5 (https=) | 2022-05-13 |
| JPWO2019237065A5 JPWO2019237065A5 (https=) | 2022-05-13 |
Family
ID=68770655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518059A Pending JP2021527130A (ja) | 2018-06-08 | 2019-06-07 | 組織傷害および集中治療後症候群の処置および予防のためのハロゲン化合物の使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210252047A1 (https=) |
| EP (1) | EP3801565A4 (https=) |
| JP (1) | JP2021527130A (https=) |
| KR (1) | KR20210018898A (https=) |
| CN (1) | CN112469422A (https=) |
| AU (1) | AU2019282820A1 (https=) |
| CA (1) | CA3102792A1 (https=) |
| IL (1) | IL279221A (https=) |
| MX (1) | MX2020013306A (https=) |
| WO (1) | WO2019237065A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX386702B (es) | 2014-02-10 | 2025-03-19 | Fred Hutchinson Cancer Center | Tratamiento con halogeno de ataque cardiaco y lesion isquemica. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248335B1 (en) * | 1997-10-29 | 2001-06-19 | Symbollon Corporation | Stabilized oral pharmaceutical composition containing iodide and iodate and method |
| CZ295765B6 (cs) * | 1998-07-29 | 2005-10-12 | Apa - Praha, S.R.O. | Léčebný přípravek s virucidním účinkem |
| GB0525504D0 (en) * | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| MX386702B (es) * | 2014-02-10 | 2025-03-19 | Fred Hutchinson Cancer Center | Tratamiento con halogeno de ataque cardiaco y lesion isquemica. |
-
2019
- 2019-06-07 US US16/972,718 patent/US20210252047A1/en not_active Abandoned
- 2019-06-07 WO PCT/US2019/036154 patent/WO2019237065A1/en not_active Ceased
- 2019-06-07 EP EP19814153.3A patent/EP3801565A4/en not_active Withdrawn
- 2019-06-07 MX MX2020013306A patent/MX2020013306A/es unknown
- 2019-06-07 CN CN201980049776.3A patent/CN112469422A/zh active Pending
- 2019-06-07 KR KR1020217000098A patent/KR20210018898A/ko not_active Ceased
- 2019-06-07 AU AU2019282820A patent/AU2019282820A1/en not_active Abandoned
- 2019-06-07 CA CA3102792A patent/CA3102792A1/en active Pending
- 2019-06-07 JP JP2021518059A patent/JP2021527130A/ja active Pending
-
2020
- 2020-12-06 IL IL279221A patent/IL279221A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014533733A5 (https=) | ||
| JP2014502641A5 (https=) | ||
| JP2016539164A5 (https=) | ||
| JP2011522876A (ja) | 永続性心房細動を予防するためのドロネダロン | |
| JP2019517542A5 (https=) | ||
| HRP20220058T1 (hr) | Sastavi i metode za smanjenje velikih neželjenih kardiovaskularnih događaja | |
| JP2019533660A5 (https=) | ||
| JP2016510326A5 (https=) | ||
| Hwang et al. | Extracorporeal membrane oxygenation for acute life-threatening neurogenic pulmonary edema following rupture of an intracranial aneurysm | |
| US20210283049A1 (en) | Intravenous sotalol hydrochloride loading and maintenance for cardiac surgery patients | |
| US20230255908A1 (en) | Methods of intravenously administering sotalol hydrochloride | |
| US20230248674A1 (en) | Methods of intravenously administering sotalol hydrochloride | |
| US20230372268A1 (en) | Methods of intravenously administering sotalol | |
| TW201416095A (zh) | 包含格米列汀與美氟明的組合藥物及其製備方法 | |
| JP2021527130A5 (https=) | ||
| JP2020527138A5 (https=) | ||
| KR102752382B1 (ko) | 안지오텐신 ii 수용체 길항제 대사물질 및 nep 억제제의 복합체의 심부전 치료에서의 용도 | |
| JP2018502924A5 (https=) | ||
| JP2016510040A5 (https=) | ||
| US20230241078A1 (en) | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement | |
| JP2021532165A5 (https=) | ||
| JPWO2019237065A5 (https=) | ||
| Franco et al. | Oral management of Steinert's disease and role of anxiolysis | |
| Stefanescu et al. | The management of post-tonsillectomy morbidity in patients with sleep apnoea | |
| Park | Multiple Angiodysplasia in the Stomach |